EFFECTS
OF ERYTHROPOIETIN IN INFANTS WITH ANEMIA OF PREMATURITY
Chen HW
Department of Pediatrics, Nanfang Hospital, Guangzhou, China
Objective: To evaluate the effects of
erythropoietin in infants with anemia of prematurity,.
Methods: 53 cases of infants with
anemia of prematurity were randomly divided into treatment group (31 cases)
and placebo group (22 cases). In the treatment group, erythropoietin was
administered subcutaneously in a dose of 200 IU/kg twice a week for 8
weeks.
Results: The hemoglobin, red blood
cell and hematocrit in the treatment group were significantly increased and
higher than the pacebo group (P<0.001) after 8 weeks.The increasing peak
is in the fifth week.No significant side effects were observed.
Conclusion: erythropoietin is effective
in the treatment of infants with anemia of prematurity.